Comparing surgical treatments for wrist injuries
Official title: TREatment of Triangular FibrOcaRtilage ComplEx Ruptures (REINFORCER): Protocol for Randomized, Controlled, Blinded, Efficacy Trial of Triangular Fibrocartilage Complex Tears
Run by Tampere University Hospital · NCT04576169 · Data updated 2026-11-12
This study tests different surgical options for treating wrist injuries to see which one helps people with wrist pain feel better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 204 (estimated) |
| Sponsor | Tampere University Hospital Academic / other |
| Locations | 9 sites (Copenhagen and 8 other locations) |
| Status | Recruiting |
| Started | October 27, 2020 |
| Main results expected | March 31, 2028 |
| Study ends | March 31, 2035 |
| Registry record updated | October 9, 2024 |
| Trial ID | NCT04576169 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years old with ulnar-sided wrist pain and a suspected TFCC tear that has not improved with non-operative treatment.
✕Probably not a fit
Patients with gross instability of the distal radioulnar joint or significant degenerative changes may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial investigates the effectiveness of different surgical strategies for treating triangular fibrocartilage complex (TFCC) injuries, which are a common cause of ulnar wrist pain. It is a multicenter, randomized, controlled trial that compares arthroscopic debridement to placebo surgery and TFCC repair to physiotherapy. Participants will be randomly assigned to one of the treatment options, and their outcomes will be assessed using the Patient-Rated Wrist Evaluation at one year post-randomization. The study aims to provide robust evidence on the best treatment approaches for these injuries.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment options for patients suffering from TFCC injuries, potentially reducing pain and enhancing wrist function.
How similar studies have gone: Previous observational studies have shown improvements in symptoms after TFCC repair, but this is one of the first randomized controlled trials to rigorously assess the efficacy of these surgical interventions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Ulnar sided wrist pain * Age more than 18 years * Suspicion of TFCC tear in clinical examination * Ability to fill the Danish, Finnish or Swedish versions of questionnaires * Symptom duration more than 3 months, and unsuccessful non-operative treatment * Central (Palmer 1A), ulnar (Palmer 1B) or radial (Palmer 1D) TFCC tear explaining the pain in arthroscopy Exclusion Criteria: * Gross instability of DRUJ which will be defined as "obvious instability in clinical examination in each forearm and wrist position" * Distal (Palmer 1C) TFCC tear in arthroscopy * Ulnocarpal or DRUJ arthrosis (Atzei class 5) * Ulnar variance ≥ +2 mm in x-ray * Age above 65 years * Rheumatoid arthritis or other inflammatory disease effecting radio- or ulnocarpal or DRUJ * Lunotriquetral instability diagnosed in arthroscopy * ECU instability * Massive tear and degenerated edges or frayed tear which fails suture (Atzei class 4A-4B)
Where it's running
-
Herlev/Gentofte University Hospital of Copenhagen
Copenhagen, Denmark Recruiting -
Hospital Sønderjylland
Sønderborg, Denmark Recruiting -
Hospital Nova of Central Finland
Jyväskylä, Central Finland, Finland Recruiting -
Oulu University Hospital
Oulu, North Ostrobothnia, Finland Recruiting -
Kuopio University Hospital
Kuopio, Northern Savonia, Finland Recruiting -
Tampere University Hospital
Tampere, Pirkanmaa, Finland Recruiting
Show 3 more locations
-
Turku University Hospital
Turku, Southwest Finland, Finland Recruiting -
Helsinki University Hospital
Helsinki, Uusimaa, Finland Recruiting -
Karolinska University Hospital
Stockholm, Sweden Recruiting
Study contacts
- Principal investigator: Antti Kaivorinne, M.D. — Tampere University Hospital
- Study coordinator: Ville M Mattila, M.D., Ph.D., Professor
- Email: ville.mattila@tuni.fi
- Phone: +3583311611
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Three-Dimensional Tumor Molds Made from Imaging to Guide Tissue Sampling
Researchers will test whether 3D-printed molds based on radiology can guide precise tissue sampling from surgically removed tumors.
-
What causes vulnerability in older adults with serious diseases and how it affects care decisions
This study tests how often vulnerability factors appear in older adults with serious illnesses and how these factors influence treatment timing, survival, and quality of life.
-
One Year of Intensive Lifestyle Treatment for Children with ISO-BMI Over 30 and Their Families
This trial tests a year-long intensive lifestyle program for kids aged 10–16 with ISO-BMI of 30 or higher, and also involves their families.
-
Bergen Four-Day Treatment for OCD, in Finland
This trial tests whether the Bergen Four-Day Treatment for OCD can be implemented in Finnish psychiatric care to help people with OCD see if the intensive program works in a real-world setting.
-
Treatments for prolonged cough in children
It tests whether an inhaled steroid helps children with dry prolonged cough and whether an antibiotic helps children with wet prolonged cough compared with placebo.
-
24-hour continuous antibiotic infusion for children using portable elastomeric pumps
This will try 24-hour continuous IV antibiotic infusions with portable elastomeric pumps for children who need intravenous antibiotics to see if the approach is safe and cost-saving for home care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.